Abstract
Valsartan is an efficacious blood pressure-lowering active pharmaceutical ingredient with highly selective antagonist of angiotensin II (type 1-receptor subtype). However, its pharmaceutical application is limited by the low oral bioavailability (~23 %), which is resulted from hydrophobic nature and poor aqueous solubility. In this study, two inclusion complexes of valsartan has been environmental-friendly synthesized using VM-1 roll mill to improve the poor oral bioavailability of valsartan by increasing its water solubility. Polysaccharide arabinogalactan from larch Larix sibirica (AG) and (2-hydroxypropyl)-β-cyclodextrin (HP-β-CD) were separately used as branched or truncated-cone inclusion carriers for valsartan. The synthesized complexes were characterized by NMR relaxation technique, DSC and powder X-ray diffraction pattern. Results showed a shorten T2 relaxation time, disappearance of valsartan endothermic peak and significant variations in X-ray pattern, indicating the formation of complexes being inclusion. In further study, physicochemical properties of valsartan and its mechanical treated complexes were investigated both in aqueous solutions and in solid state. It was found both of the two inclusion complexes successfully improved the solubility of valsartan (Valsartan/AG inclusion complex increased from 0.24 to 0.42 g L−1; Valsartan/HP-β-CD inclusion complex increased from 0.24 to 0.82 g L−1, +37 °C). On the other hand, the rapid storage test showed the inclusion formation of valsartan kept a similar stability as its pure form (+40 °C for 2 months). Taking into account of above results, it is concluded the two synthesized inclusion complexes are promising to improve the bioavailability of valsartan with a better solubility and without changing its stability.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig6_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig7_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig8_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig9_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig10_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10847-016-0608-1/MediaObjects/10847_2016_608_Fig11_HTML.gif)
Similar content being viewed by others
References
Alavijeh, M.S., Chishty, M., Qaiser, M.Z., Palmer, A.M.: Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. Neurorx. J. Am. Soc. Exp. Neuro Ther. 2, 554–571 (2005)
Yu, L.X., Amidon, G.L., Polli, J.E., et al.: Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 19, 921–925 (2002)
Shende, P.K., Gaud, R.S., Bakal, R., Patil, D.: Effect of inclusion complexation of meloxicam with β-cyclodextrin and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies. Colloids Surf. B 136, 105–110 (2015)
Loftsson, T., Hreinsdóttir, D., Másson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18–28 (2005)
Savic, I.M., Nikolic, V.D., Savic-Gajic, I., et al.: Investigation of properties and structural characterization of the quercetin inclusion complex with (2-hydroxypropyl)-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 82, 383–394 (2015)
Tačić, A., Savić, I., Nikolić, V., Savić, I., Ilić-Stojanović, S., Ilić, D., Petrović, S., Popsavin, M., Kapor, A.: Inclusion complexes of sulfanilamide with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 80, 113–124 (2014)
Chistyachenko, Y.S., Dushkin, A.V., Polyakov, N.E., et al.: Polysaccharide arabinogalactan from larch Larix sibirica as carrier for molecules of salicylic and acetylsalicylic acid: preparation, physicochemical and pharmacological study. Drug. Deliv. 22, 400–407 (2015)
Semcheddine, F., Guissi, N.E.I., Liu, X.Y., et al.: Effects of the preparation method on the formation of true nimodipine SBE-β-CD/HP-β-CD inclusion complexes and their dissolution rates enhancement. AAPS. Pharmscitech. 16, 704–715 (2015)
Ghosh, A., Biswas, S., Ghosh, T.: Preparation and evaluation of silymarin β-cyclodextrin molecular inclusion complexes. J. Young Pharm. 3, 205–210 (2011)
Ramesh, C.N., Bhuvaneswara, R.C., Balakrishnan, M., Chandra Sekhar, K.B.: Preparation and characterization of pioglitazone hcl solid inclusion complex—an solubility enhancement technique. Int. J. Biopharm. 5, 180–183 (2014)
Delori, A., Friščić, T., Jones, W.: The role of mechanochemistry and supramolecular design in the development of pharmaceutical materials. CrystEngComm 14, 2350–2362 (2012)
Dushkin, A.V.: Potential of mechanochemical technology in organic synthesis and synthesis of new materials. Chem. Sustain. Dev. 12, 251–273 (2004)
Fujio, O.: Mechanochemistry of polymers and its applications. Nippon Gomu Kyokaishi. 42, 295–304 (1969)
Aresta, M., Dibenedetto, A., Pastore, T.: Mechanochemistry: an old technology with new applications to environmental issues. Decontamination of polychlorobiphenyl-contaminated soil by high-energy milling in the solid state with ternary hydrides. In: Lichtfouse, E., Schwarzbauer, J., Robert, D. (eds.) Environmental Chemistry: Green Chemistry and Pollutants in Ecosystems, pp. 553–559. Springer, Berlin (2005)
James, S.L., Adams, C.J., Bolm, C., et al.: Mechanochemistry: opportunities for new and cleaner synthesis. Chem. Soc. Rev. 41, 413–447 (2012)
Dushkin, A.V.: Mechanochemical synthesis of organic compounds and rapidly soluble materials. In: Sopicka-Lizer, M. (ed.) High-energy Ball Milling, pp. 224–247. Woodhead Publishing Limited, Oxford (2010)
Dushkin, A.V., Tolstikova, T.G., Khvostov, M.V., Tolstikov, G.A.: Complexes of polysaccharides and glycyrrhizic acid with drug molecules, mechanochemical synthesis and pharmacological activity. In: Karunaratn, D.N. (ed.) The Complex World of Polysacchraids, pp. 573–602. Intech Publisher, Oxford (2012)
Shakhtshneider, T.P., Vasilchenko, M.A., Politov, A.A., Boldyrev, V.V.: Mechanochemical preparation of drug-carrier solid dispersions. J. Therm. Anal. 48, 491–501 (1997)
Criscione, L., Gasparo, M., Buhlmayer, P., et al.: Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Br. J. Pharmacol. 110, 761–771 (1993)
Flesch, G., Lloyd, M.P.: Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man. Eur. J. Clin. Pharmacol. 52, 115–120 (1997)
Raja Rajeswari, K., Abbulu, K., Sudhakar, M.: Development, characterization and solubility study of solid dispersion of valsartan. J. Chem. Pharm. Res. 3, 180–187 (2011)
Mahapatra, A.K., Murthy, P.N., Biswal, S., Mahapatra, A.P.K., Pradhan, S.P.: Dissolution enhancement and physicochemical characterization of valsartan in solid dispersions with β-CD, HP-β-CD, and PVP K-30. Dissolution Technol. 18, 39–45 (2011)
Kshirsagar, S.J., Bhalekar, M.R., Madgulkar, A.R., Sable, P.N., Gupta, S.R.: Dissolution improvement of poorly water soluble drug valsartan and improving flow properties of solid dispersion. Lat. Am. J. Pharm. 29, 393–400 (2010)
Kelly, G.S.: Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Altern. Med. Rev. 4, 96–103 (1999)
Monograph.: Larch arabinogalactan. Alern. Med. Rev. 5, 463–466 (2000)
Zhang, Y., Meng, F.C., Cui, Y.L., Song, Y.F.: Enhancing effect of hydroxypropyl-β-cyclodextrin on the intestinal absorption process of genipin. J. Agric. Food Chem. 59, 10919–10926 (2011)
Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug. Discov. 12, 1023–1035 (2004)
Tian, J., Yao, Y., Shen, S., Zheng, X., Liu, C., Han, X.: Effect of roller mill and planetary ball mill on starch damage of wheat with different hardness. J. Henan Univ. Technol. 36, 8–15 (2015)
Mccormick, P.G., Ding, J., Miao, W.F., Street, R.: Process for the production of ultrafine particles. United State Patent. No. 6203768 B1[P] (2001)
Kubota, T., Takaya, H., Hasumi, M., et al.: Method for producing single nucleus detergent particles. United State Patent. No 6602846. B1[P] (2003)
Dushkin, A.V., Chistyachenko, Y.S., Tolstikova, T.G., et al.: Pharmacological and physicochemical properties of mechanochemically synthesized supramolecular complexes of acetylsalicylic acid and polysaccharide arabinogalactan from larches Larix sibirica and Larix Gmelinii. Dokl. Biochem. Biophys. 451, 180–182 (2013)
Emsley, J.W., Freeney, J., Sutcliffe, L.H.: High Resolution Nuclear Magnetic Resonance Spectroscopy. Pergamon press, Oxford (1965)
Popova, M.V., Tchernyshev, Y.S., Michel, D.: NMR investigation of the short-chain ionic. Langmuir 20, 632–636 (2004)
Higuchi, T., Connors, K.A.: Phase solubility techniques. In: Reilly, C.N. (ed.) Advances in Analytical Chemistry and Instrumentation, pp. 117–212. Wiley-Interscience, New York (1965)
Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645–666 (2007)
Koptyaeva, E.I., Fatykhov, A.A., Ivanov, S.P., et al.: Solid-phase mechanochemical synthesis of arabinogalactan and chlorsulfuron complexes. Russ. J. Appl. Chem. 85, 788–793 (2012)
Bilensoy, E., Gürkaynak, O., Doğan, A.L., et al.: Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery. Int. J. Pharm. 347, 163–170 (2008)
Sallas, F., Darcy, R.: Amphiphilic cyclodextrins-advances in synthesis and supramolecular chemistry. Eur. J. Org. Chem. 2008, 957–969 (2008)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Du, L., Dushkin, A.V., Chistyachenko, Y.S. et al. Investigation the inclusion complexes of valsartan with polysaccharide arabinogalactan from larch Larix sibirica and (2-hydroxypropyl)-β-cyclodextrin: preparation, characterization and physicochemical properties. J Incl Phenom Macrocycl Chem 85, 93–104 (2016). https://doi.org/10.1007/s10847-016-0608-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-016-0608-1